Home›Companies›Healthcare›Novel Microdevices

Novel Microdevices, Inc.

Develops portable molecular testing equipment for clinics and health posts.

Updated Nov 10, 2026·Latest SEC filing Apr 27, 2026·Suggest an edit

About Novel Microdevices

Novel Microdevices is a private company based in Baltimore, Maryland, incorporated in 2021 in Delaware. It has reported $9,167,000 raised in five offerings on Form D since February 2021. Its chief executive is Andrea Pais.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 27, 2026Apr 27, 2026$1,000,000of $8.0M target1$1.0MDebt, Convertible Promissory NoteRule 506(b)Form D ↗
Dec 27, 2024Jan 7, 2025$567,000of $3.0M target1$567KDebtRule 506(b)Form D ↗
Dec 28, 2023Jan 5, 2024$1,850,000of $6.0M target3$616KEquity, Simple Agreement for Future EquityRule 506(b)Form D ↗
Feb 10, 2021Feb 25, 2021amended Nov 1, 2021$1,375,000of $2.0M target10$137KConvertible Promissory NoteRule 506(b)Form D/A ↗2 earlier filings
Feb 10, 2021Dec 21, 2020amended Jan 17, 2023$4,375,000of $6.5M target29$150KDebtRule 506(b)Form D/A ↗4 earlier filings
Total, five offerings$9,167,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Novel Microdevices's Form D filed Apr 27, 2026.

Earlier filings also listed Deborah Hemingway (director, last listed Jan 2025) and Robert Storey (director, last listed Jan 2023).

Sources

  1. SECNovel Microdevices, Inc. Form D/A, filed Apr 28, 2022
  2. SECNovel Microdevices, Inc. Form D/A, filed Feb 2, 2022
  3. SECNovel Microdevices, Inc. Form D/A, filed Oct 29, 2021
  4. SECNovel Microdevices, Inc. Form D, filed Feb 25, 2021
  5. SECNovel Microdevices, Inc. Form D/A, filed Feb 25, 2021
  6. SECNovel Microdevices, Inc. Form D, filed Dec 21, 2020
  7. SECNovel Microdevices, Inc. filing history